Assume Titan, once commercialized, has a profit margin of 20% (industry standard is 30%+) Assume 600 M outstanding shares (additional dilution coming) Assume PE ratio of 30 (ISRG was 51 in 2016)
Let's hope for a $10 PPS We would need profit of $0.33 per share We would need revenue of $1.67 per share That's total revenue of $1.0 B needed With a projected medical robotics market of more than $20 B per year, that's only a 5% penetration of the market.